Trial of CX 601 in the treatment of complex perianal fistulas in children and adolescents with Crohn's disease.

Trial Profile

Trial of CX 601 in the treatment of complex perianal fistulas in children and adolescents with Crohn's disease.

Planning
Phase of Trial: Phase III

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs CX 601 (Primary)
  • Indications Rectal fistula
  • Focus Registrational; Therapeutic Use
  • Sponsors TiGenix
  • Most Recent Events

    • 16 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top